Growth differentiation factor 15 (GDF15): A survival protein with therapeutic potential in metabolic diseases

Seung Joon Baek1, Thomas Eling2

  • 1Bldg 81 Rm 413, Laboratory of Signal Transduction, College of Veterinary Medicine, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea..

Pharmacology & Therapeutics
|February 22, 2019
PubMed

Insights

Growth Differentiation Factor 15 (GDF15) plays a role in cancer and obesity. Its receptor, GFRAL, was recently identified, impacting research on body weight regulation and metabolic diseases.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Oncology

Background:

  • Growth Differentiation Factor 15 (GDF15), also known as NSAID activated gene-1 (NAG-1), is involved in numerous biological processes and diseases, including cancer and obesity.
  • Both intracellular and circulating GDF15 influence energy homeostasis and body weight regulation.
  • GFRAL, a glial-derived neurotrophic factor receptor alpha family member, was recently identified as the receptor for mature GDF15.

Purpose of the Study:

  • To review the role of GDF15 in cancer and energy homeostasis, focusing on obesity and body weight regulation.
  • To discuss the impact of the GDF15 receptor identification on these research areas.
  • To explore the therapeutic potential of GDF15 in obesity and metabolic diseases.

Main Methods:

  • Literature review focusing on GDF15, GFRAL, cancer, obesity, and metabolic diseases.
  • Analysis of existing studies on GDF15's biological functions and its receptor.
  • Discussion of therapeutic strategies involving GDF15.

Main Results:

  • GDF15 is implicated in cancer and the regulation of energy homeostasis and body weight.
  • The identification of GFRAL as the GDF15 receptor provides new insights into its mechanism of action.
  • GDF15 shows potential as a pharmacological agent for treating obesity and metabolic disorders.

Conclusions:

  • The identification of the GDF15 receptor, GFRAL, has significantly advanced our understanding of GDF15's role in cancer and metabolic regulation.
  • GDF15 represents a promising therapeutic target for obesity and related metabolic diseases.
  • Further research into GDF15 and GFRAL signaling pathways could lead to novel treatment strategies.

Related Concept Videos

Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
210
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
551
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.8K
Factors Influencing Microbial Growth: pH01:29

Factors Influencing Microbial Growth: pH

Microorganisms are classified as acidophiles, neutrophiles, or alkaliphiles based on their pH growth preferences, reflecting their adaptations to specific environments. Maintaining a stable intracellular pH is critical for macromolecular stability and enzymatic activity, which can be challenged by external pH variations.Neutrophiles, such as Escherichia coli, grow optimally between pH 5.5 and 8.0. These microorganisms inhabit neutral or slightly acidic environments and employ mechanisms like...
1.1K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.8K
What is Metabolism?00:52

What is Metabolism?

Overview
131.7K